|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Loss on discontinued operations | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Stock-based compensation expense | |||||
| Non-cash interest expense | |||||
| Depreciation expense | |||||
| Impairment expense | |||||
| Loss on disposal of equipment | |||||
| Amortization of intangible assets | |||||
| Change in warrant valuation | |||||
| Deferred income tax expense | |||||
| Loss (gain) on extinguishment of debt | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Contract assets | |||||
| Inventory | |||||
| Prepaid expenses and other assets | |||||
| Accrued interest | |||||
| Accounts payable, accrued expenses and other liabilities | |||||
| Net cash (used in) provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Acquisition of IriSys, net of cash acquired | |||||
| Purchases of property and equipment | |||||
| Purchases of short-term investments | |||||
| Proceeds from maturity of investments | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from issuance of stock, net of costs | |||||
| Proceeds from issuance of debt | |||||
| Proceeds from sales-lease back liability | |||||
| Payment of debt principal | |||||
| Payment of financing costs | |||||
| Net payments related to vesting of restricted stock units | |||||
| Net proceeds related to exercise of stock options | |||||
| Net cash provided by financing activities | |||||
| Net (decrease) increase in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of period | |||||
| Cash and cash equivalents, end of period | |||||
| Supplemental disclosures of cash flow information: | |||||
| Cash flows used in operating activities, discontinued operations | |||||
| Cash flows used in investing activities | |||||
| Cash flows used in financing activities | |||||
| Net decrease in cash and cash equivalents from discontinued operations | |||||
| Cash paid for interest | |||||
| Purchases of property, plant and equipment included in accrued expenses and accounts payable | |||||
| Disposals of property, plant and equipment | |||||
| Fair value of warrants issued in connection with financing facility | |||||
| Offering costs included in accounts payable and accrued expenses | |||||
| Deferred financing costs included in accounts payable and accrued expenses | |||||
| Reclassification of deferred financing costs to equity | |||||
| Fair value of shares issuable to former equity holders of IriSys | |||||
| Fair value of note issued to former equity holder of IriSys | |||||
| Issuance of common stock to reduce debt principal and accrued exit fees | |||||
| Issuance of common stock to settle interest obligations | |||||
Loading...